相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
Nathan D. Mathewson et al.
CELL (2021)
CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential
Vanaja Konduri et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy
Xu Lei et al.
CANCER LETTERS (2020)
Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
Long Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Transcription/Expression of KLRB1 Gene as A Prognostic Indicator in Human Esophageal Squamous Cell Carcinoma
Guangwei Zhang et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2020)
Mechanisms of Multidrug Resistance in Cancer Chemotherapy
Karol Bukowski et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The identification and functional analysis of CD8+PD-1+CD161+ T cells in hepatocellular carcinoma
Zhixuan Li et al.
NPJ PRECISION ONCOLOGY (2020)
Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma
Chaoqi Zhang et al.
ONCOIMMUNOLOGY (2020)
Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment
Zehang Jiang et al.
EBIOMEDICINE (2019)
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin
Dae-Won Lee et al.
CLINICAL CANCER RESEARCH (2019)
Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
Xuanwen Bao et al.
FRONTIERS IN ONCOLOGY (2019)
DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
Huimin Dan et al.
ONCOTARGETS AND THERAPY (2019)
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
Lukas Bunse et al.
NATURE MEDICINE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells
Ayako Kurioka et al.
FRONTIERS IN IMMUNOLOGY (2018)
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
Pakawat Chongsathidkiet et al.
NATURE MEDICINE (2018)
Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2018)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
Nathan O. Siemers et al.
PLOS ONE (2017)
Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
Marie-Caroline Dieu-Nosjean et al.
IMMUNOLOGICAL REVIEWS (2016)
Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction
Stephen O. Mathew et al.
ONCOTARGET (2016)
The role of myeloid cells in cancer therapies
Camilla Engblom et al.
NATURE REVIEWS CANCER (2016)
Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
Maarten P. G. Massink et al.
BMC CANCER (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types
Peter S. Linsley et al.
PLOS ONE (2015)
Tumor-Associated Macrophages: From Mechanisms to Therapy
Roy Noy et al.
IMMUNITY (2014)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
The number of CD161 positive Th17 cells are decreased in head and neck cancer patients
Rebecca Kesselring et al.
CELLULAR IMMUNOLOGY (2011)
LLT1-mediated Activation of IFN-γ Production in Human Natural Killer Cells Involves ERK Signalling Pathway
N. D. Bambard et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Functional consequences of interactions between-human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells
David B. Rosen et al.
JOURNAL OF IMMUNOLOGY (2008)
Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients
Gordana Konjevic et al.
CLINICAL & EXPERIMENTAL METASTASIS (2007)
Increased frequency of CD4+ cells expressing CD161 in cancer patients
Eleni G. Iliopoulou et al.
CLINICAL CANCER RESEARCH (2006)
Cutting edge: Lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor
DB Rosen et al.
JOURNAL OF IMMUNOLOGY (2005)
分享论文
